Smooth Muscle Cell Pathophysiology and Advanced Glycation End Products (AGEs)

E-ISSN： 1873-5592|11|7|875-881

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.7, 2010-07, pp. : 875-881

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advanced Glycation End-products Enhance Calcification in Vascular Smooth Muscle Cells

By Ren X Shao H Wei Q Sun Z Liu N

The Journal of International Medical Research, Vol. 37, Iss. 3, 2009-05 ,pp. : 847-854

Field House Publishing

Access to resources Recommend Favorite

Advanced Glycation End Products (AGEs), Oxidative Stress and Diabetic Retinopathy

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-03 ,pp. : 362-368

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced Glycation End Products (AGEs) and their Receptor (RAGE) System in Diabetic Retinopathy

Current Drug Discovery Technologies, Vol. 3, Iss. 1, 2006-03 ,pp. : 83-88

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Advanced Glycation End Products (AGEs) and Oxidative Stress in Diabetic Retinopathy

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 962-968

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 969-972

Bentham Science Publishers

Access to resources Recommend Favorite